The CIS Region: Excellent Potential for Patient Recruitment but is there any Risk to Quality?
The number of clinical trials worldwide is increasing more than 10% each year due to the new diseases, further research for better health products and development of new drugs. Though, for a successful clinical trial, there is a major challenge – patient...
The Predicted Impact of the ISO IDMP Standards Implementation Process Carried Out by the European Medicines Agency
Current Background in the EU The IDMP (Identification of Medicinal Products) is a general term by which the 5 ISO data standards are referenced: ISO 11615 (regulated medicinal product information), ISO 11616 (regulated pharmaceutical product information), ISO 11238...
Running a clinical trial in the Baltic states
In the past five years, an average of 175 clinical trials are being initiated in the Baltic states each year. An average of 64,8% of the population in the Baltic states are in the age from 15 to 65 years old, the main target audience for clinical trials. Furthermore,...
